Proventys' mission is to improve the way care is delivered to patients by helping physicians embrace predictive, personalized, and preventive approaches to medicine that lead to superior outcomes. At the heart of our work is the application of science and the creation of knowledge that will help guide our efforts as we advance personalized medicine delivered at the point of care.

We invite you to read peer-reviewed articles, studies and perspectives from our founders and scientific leaders. We will also provide whitepapers and other pieces soon as we expand our research and development activities and overall work in the industry.

Please note that some of the above may reference Proventys PDx Oncology^TM which is under review with the FDA (de novo) and is not available for sale in the United States.